These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38375344)

  • 21. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
    Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
    Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study.
    Shin DW; Lee SH; Kim TH; Yun SJ; Nam JK; Jeon SH; Park SC; Jung SI; Park JH; Park J
    Cancer Res Treat; 2019 Apr; 51(2):556-567. PubMed ID: 30011984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
    O'Donnell PH; Arkenau HT; Sridhar SS; Ong M; Drakaki A; Spira AI; Zhang J; Gordon MS; Degboe AN; Gupta AK; Mukhopadhyay P; Huang W; Abdullah SE; Angra N; Roskos LK; Guo X; Friedlander T
    Cancer; 2020 Jan; 126(2):432-443. PubMed ID: 31581306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer.
    Theodoropoulos GE; Karantanos T; Stamopoulos P; Zografos G
    Tech Coloproctol; 2013 Feb; 17(1):27-38. PubMed ID: 23065134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-reported Quality of Life in Patients with Primary Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy with and Without Concurrent Radiation Therapy to the Prostate in a Prospective Randomised Clinical Trial; Data from the HORRAD Trial.
    Boevé L; Hulshof MCCM; Verhagen PCMS; Twisk JWR; Witjes WPJ; de Vries P; van Moorselaar RJA; van Andel G; Vis AN
    Eur Urol; 2021 Feb; 79(2):188-197. PubMed ID: 32978014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
    Soffietti R; Kocher M; Abacioglu UM; Villa S; Fauchon F; Baumert BG; Fariselli L; Tzuk-Shina T; Kortmann RD; Carrie C; Ben Hassel M; Kouri M; Valeinis E; van den Berge D; Mueller RP; Tridello G; Collette L; Bottomley A
    J Clin Oncol; 2013 Jan; 31(1):65-72. PubMed ID: 23213105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer.
    de Vries J; Bras L; Sidorenkov G; Festen S; Steenbakkers RJHM; Langendijk JA; Witjes MJH; van der Laan BFAM; de Bock GH; Halmos GB
    Oral Oncol; 2020 Dec; 111():105020. PubMed ID: 33045628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of Life with Monoclonal Antibody Therapies for Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review.
    Annakib S; Fiteni F; Houédé N
    Eur Urol Oncol; 2023 Oct; 6(5):467-476. PubMed ID: 37244802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-World Effectiveness, Safety, and Health-Related Quality of Life in Patients Receiving Adjuvant Nivolumab for Melanoma in Belgium and Luxembourg: Results of PRESERV MEL.
    Rogiers A; Willemot L; McDonald L; Van Campenhout H; Berchem G; Jacobs C; Blockx N; Rorive A; Neyns B
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and Safety of Thulium Fiber Laser in the Conservative Management of Patients with Upper Tract Urothelial Carcinoma.
    Proietti S; Johnston T; Pupulin M; Di Pietro S; Spagna S; Rico L; Lucianò R; Ventimiglia E; Villa L; Gaboardi F; Giusti G
    Eur Urol Open Sci; 2022 Dec; 46():99-104. PubMed ID: 36506254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review.
    Wang Z; Shi H; Xu Y; Fang Y; Song J; Jiang W; Xia D; Wu Z; Wang L
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy.
    Miyake M; Iida K; Nishimura N; Inoue T; Matsumoto H; Matsuyama H; Fujiwara Y; Komura K; Inamoto T; Azuma H; Yasumoto H; Shiina H; Yonemori M; Enokida H; Nakagawa M; Fukuhara H; Inoue K; Yoshida T; Kinoshita H; Matsuda T; Fujii T; Fujimoto K;
    Eur Urol Open Sci; 2022 Jul; 41():95-104. PubMed ID: 35813249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors.
    Gacci M; Saleh O; Cai T; Gore JL; D'Elia C; Minervini A; Masieri L; Giannessi C; Lanciotti M; Varca V; Simonato A; Serni S; Carmignani G; Carini M
    Health Qual Life Outcomes; 2013 Mar; 11():43. PubMed ID: 23497292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.
    Efficace F; Castagnetti F; Martino B; Breccia M; D'Adda M; Angelucci E; Stagno F; Cottone F; Malato A; Trabacchi E; Capalbo SF; Gobbi M; Visani G; Salvucci M; Capodanno I; Tosi P; Tiribelli M; Scortechini AR; Levato L; Maino E; Binotto G; Gugliotta G; Vignetti M; Baccarani M; Rosti G
    Cancer; 2018 May; 124(10):2228-2237. PubMed ID: 29499087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomised Controlled Trial.
    Mastroianni R; Tuderti G; Anceschi U; Bove AM; Brassetti A; Ferriero M; Zampa A; Giannarelli D; Guaglianone S; Gallucci M; Simone G
    Eur Urol Focus; 2022 Mar; 8(2):465-471. PubMed ID: 33712389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravesical Recurrence After Radical Nephroureterectomy of Upper Urinary Tract Urothelial Carcinoma: A Large Population-Based Investigation of Clinicopathologic Characteristics and Survival Outcomes.
    Wu J; Xu PH; Luo WJ; Dai B; Shen YJ; Ye DW; Wang YC; Zhu YP
    Front Surg; 2021; 8():590448. PubMed ID: 33693025
    [No Abstract]   [Full Text] [Related]  

  • 40. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
    Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
    Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.